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Introduction
Use of recommended therapies is essential to improving health outcomes and maintaining
quality of life for people with cystic fibrosis (CF). People with CF face a constellation of
challenges that can affect their ability to follow their care team’s recommendations related
to prescription and non-prescription medication orders. Factors outside the patient’s
control, such as medication costs, complicated insurance approval processes, and the
responsibilities associated with managing everyday lives, can impact their access to
medications. The high out-of-pocket cost of medications can become a major barrier to the
use of recommended therapies for people with CF as well as for many other chronic
conditions. One study found nearly one of every six insured Americans did not fill a
prescription or skipped at least one dose in the previous year due to the cost.1 This is even
more common among the uninsured; one in three uninsured people in the U.S. did not fill a
prescription or skipped a dose because of the cost.1 While the vast majority of people with
CF are insured, that does not mean that they are shielded from burdensome out-of-pocket
costs. Even with insurance coverage, people with CF are often responsible for cost sharing
and other out-of-pocket expenses that can quickly add up.
In this brief, we attempt to better understand the factors associated with underuse of
prescription medications due to cost for people with CF. We describe the characteristics of
people who experience this challenge, including insurance type and gaps in coverage, costs
to the patient, the financial hardships they face, and the ways that these hardships affect
use of CF care center services.

We find that there is a clear association between financial challenges or coverage
inadequacies and underuse of prescription medications among people with CF.

Methods
Under contract from the Cystic Fibrosis Foundation, researchers from the Milken Institute
School of Public Health at George Washington University developed an online survey, The
2019 Cystic Fibrosis Health Insurance Survey, to understand unmet medical need,
coverage, access to care, and financial hardship among people with cystic fibrosis in the
U.S.2 As part of the survey, participants were asked a series of questions to determine any
unmet prescription drug need due to cost. Unmet prescription drug need – which we refer
to throughout this report as “unmet Rx need” – was determined to be present if the
respondents indicated they had skipped medications doses, taken less medicine than
prescribed, or delayed filling a prescription in the past year due to the cost.
Survey participants were recruited with assistance from the Cystic Fibrosis Foundation.
The Foundation shared the survey across the U.S. using social media and listservs, while
also encouraging providers at CF care centers to share the survey with their patients. All
respondents represent a unique person with CF (even if the survey was filled out by a
parent on behalf of their child or a caregiver on behalf of someone with CF). The crosssectional survey was fielded from July to December 2019. The final sample includes 1,846
participants. The sample was weighted to reflect the parameters of the CF Foundation’s
2019 Patient Registry Annual Data Report; it is representative of the population of
individuals in the U.S. who have CF and who seek care at one of the 133 accredited care
centers.3 Survey weights were applied to adjust for non-responses by age group and
insurance type.4
Descriptive and bivariate quantitative analyses were conducted to explore the
subpopulation with unmet Rx need and make comparisons to those whose Rx needs are
met. Multiple logistic regressions were also utilized to examine the association between
financial and coverage-related risk factors, underutilization of care center services, and
unmet Rx need.
This survey was conducted before the COVID-19 outbreak and overlapped with the October
2019 approval of Trikafta®, a highly effective treatment that could eventually be available
to 90% of people with CF. Any additional challenges with COVID-19 regarding access to
care and financial hardship will not be captured in this issue brief.

Demographics
Overall, one out of every four people with CF
(24%) indicated that they had an unmet Rx
need in 2019 (Figure 1).
Unmet Rx need varies depending on some
characteristics of people with CF. Gender, race,
ethnicity, geographic area, and employment, however, do not have a significant association
with unmet Rx need. Our data indicate a potentially large disparity across race on unmet Rx
need. In our sample, 37% of Black or African American people with CF indicate unmet Rx
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compared to 24% of white people with CF. Given that only 3% of the total sample is Black,
however, these differences by race do not hold statistical significance.
Unmet Rx need varies greatly by age. As shown in Figure 2, one third of adults with CF have
unmet Rx need due to cost. Children (0-17 years old) are less likely to report skipped or
delayed medications compared to adults ages 18 and above (13% versus 34%
respectively). The odds of unmet Rx need are three times higher for adults than children
(p<.001), holding insurance and household income constant.

Table 1 showcases the odds of unmet Rx need by differences in age group, while controlling
for differences in household income and insurance.
Table 1. Adjusted Odds Ratio of Unmet Rx Need by Age of Person with CF
Age
Adjusted Odds Ratio
0-17
18-35
36+

(Reference)
3.268***
3.292***

Note: Odds ratios are adjusted to hold household income and insurance
constant. *** Denotes there is a statistically significant association between
the age group and unmet prescription drug need at a p-value <.001.

The odds of unmet Rx need are three times higher for adults than children (p<.001),
holding insurance and household income constant. This may be due to the reduction of
parental support in managing care or increased risk of financial instability among adults.
Children may be granted more protections through coverage, financial assistance
programs, or the financial stability of parents or guardians.
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Insurance
In Figure 3, we look more closely at unmet Rx need due to cost within different coverage
groups. About one in five people with CF with Medicaid or private insurance have delayed
or skipped medications due to cost. A larger portion of Medicare beneficiaries and people
with CF dually insured by Medicaid and Medicare have unmet Rx need (42% and 32%
respectively).

In Table 2, we examine the odds of unmet Rx need due to cost if a person with CF has some
public insurance compared to private insurance, while controlling for differences in age
and household income.
Table 2. Adjusted Odds Ratio of Unmet Rx Need by Insurance Type of Person with CF
Insurance Type
Adjusted Odds Ratio
P-value
Private
Medicaid, CHIP, State Program
Medicare
Dual

(Reference)
0.854
1.430
0.715

(Reference)
0.337
0.074
0.290

Note: Odds ratios are adjusted to hold age and household income constant. P-values suggest that the
relationship between insurance types and unmet Rx need is not statistically significant at a p<.05.

Medicare beneficiaries stand out as having an increased risk of unmet Rx need. This is
in part because the majority of people with CF who qualify are sicker; and in part because
of the way that Medicare functions, where beneficiaries face cost-sharing requirements
without a catastrophic limit that is common to private insurance plans. The cost of
coinsurance and aggregate out-of-pocket expenses may impose a higher financial burden
on Medicare beneficiaries and increase the risk of unmet Rx need.
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The odds of unmet Rx need are 43% higher for Medicare beneficiaries than individuals who
are privately insured, controlling for age and household income (p=.07). Associations
between insurance type and unmet Rx need lose statistical significance when we adjust for
differences by age. Table 1 shows that unmet Rx need is more attributable to age than to
differences in coverage. The odds of unmet Rx need are not significantly different among
Medicaid beneficiaries (including those dually covered by Medicare) and the privately
insured.

Gaps in Coverage
Fewer than one percent of people with CF indicated that they were uninsured at the time
they completed the survey. Given the importance of insurance coverage for people with CF,
we asked survey respondents who had insurance coverage at the time of the survey if there
was a time in the past year when they had a gap in coverage – in effect whether they were
uninsured for any part of the previous 12 months. The majority of respondents (93%) had
coverage for the entire 12-month period. Yet our study indicates that people with any gap
in coverage are particularly vulnerable to going without their necessary medications.

As shown in Figure 4, 74% of people with CF who had a gap in coverage also reported
some unmet Rx need. This explains why it’s so vital for people with CF to maintain
coverage at all times. A minor gap in coverage can have an immediate effect on someone’s
ability to get care. This compares to 20% of people who had coverage for the full prior 12month period who indicate that they had some difficulty accessing Rx due to cost.

Costs to the Patient

The complex array of CF-related medications, services, and equipment required for CFmanagement can be extremely costly. Though most people with CF have some form of
insurance to help cover these costs, patients still face the burden of cost sharing and other
out-of-pocket expenses. Even when individual co-payments or cost-sharing are relatively
modest for any single drug or service, the multitude of out-of-pocket expenses can quickly
4

add up. So too can the costs of monthly insurance premiums and deductibles. To estimate
the total cost that the patient incurs managing their health care, participants were asked to
report how much they spend on household’s premiums, deductibles, and other out-ofpocket expenses.5 These costs to the patient could include the premiums for a family plan
or other household expenses that are not directly attributable to the person with CF. The
median out-of-pocket expenses that people with CF pay is $8,244. Figure 5 shows unmet Rx
drug need by total annual health care costs.

As the out-of-pocket expenses accrued increases within a household, the likelihood of
unmet Rx need also increases. Thirty-one percent (31%) of people with CF who spend
$20K or more annually out-of-pocket report that they have some unmet Rx need.
However, there is a significant risk of unmet need regardless of total cost to the
patient. For instance, 22% of the group of people who spend $10K or less annually on
their care report some unmet Rx need.
While out-of-pocket expenses are associated with increases in the likelihood of unmet Rx
need, these expenses do not appear to be as strong a predictor of unmet Rx need as
Medicare coverage, household income, or age. Unmet need is fairly distributed by out-ofpocket expenses, with people who are paying more being somewhat more likely to
experience unmet Rx need. Much of this may be associated with age and income. Children
and young adults with CF tend to pay less out-of-pocket expenses than older adults with
CF; expenses accrued are dependent on the coverage the person with CF has and often is
associated with income level.
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Even people who pay relatively little out of pocket may still face some unmet Rx need.
Nonfinancial factors such as transportation, health literacy, cultural differences, and
provider availability can play a role in reducing patients’ access to needed health care
services.6 For example, the cost of transportation to obtain prescriptions may be high
enough that it leads to delaying or skipping medications. For people with CF, over-thecounter non-prescription medications may not be covered by state Medicaid programs
therefore putting additional financial pressure on the patient to purchase these products to
fully meet Rx needs. Participants were also asked if they have some form of financial
assistance, such as grants from care centers or patient assistance programs from drug
companies. Three-quarters of people with CF (74%) reported they have at least one

form of financial assistance, although for some, this does not adequately relieve the
financial need; 28% of people with CF within that group have some unmet Rx need
even with these extra supports.

Financial Burden
Household Finances

In order to estimate financial burden within a person with CF’s household, we asked survey
respondents to indicate which scenario best describes their household’s financial situation:
whether they live comfortably, meet basic expenses with a little leftover for extras, just
meet basic expenses, or don’t have enough to meet basic expenses (Figure 6).

About one in ten people with CF (12%) who live comfortably have delayed or skipped
prescriptions due to cost. As a person with CF’s household financial situation worsens,

however, the likelihood of unmet Rx need increases. 42% of people with CF who don’t
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have enough to meet basic expenses report that they delayed or skipped medications
due to cost.
Figure 7 showcases the probability of unmet Rx need by household income, while adjusting
for differences in age and insurance.
Figure 7. Adjusted Predictions of Unmet Rx Need
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Household Income

As household income increases, the probability of unmet Rx needs decreases. If you
have a household income less than $30,000, you have 29% chance of unmet Rx need
(p<0.001). The odds of unmet Rx need in these households is two and a half times higher
than households with $150,000 or more (p<.001). People with CF in households with
$150,000 or more in income have a 15% chance of unmet Rx need, and, therefore, are also
not immune to the financial burden of managing CF therapies. Clearly, while income
protects people with CF from unmet Rx needs, it does not completely eliminate the
likelihood that these challenges exist.

Problems Paying for Medications and Supplements
In addition to the focus on unmet Rx need, we also looked at the affordability of specific
medications. We worked with the CF Foundation to identify common prescription and
over-the-counter medications and supplements. About one-third (32%) of people with CF
had problems affording these common CF medications.
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Figure 8 shows that between 11% and 20% of people with CF have a problem affording
certain medications or supplements. For example, 17% of the sample had a problem paying
for chronic inhaled antibiotics; and 15% had a problem paying for CFTR modulators. Our
data indicate that people with CF who had problems paying for medications may be at risk
for delayed or skipped prescription medications. There are many social factors at play that
may contribute to this. Vitamins and supplements were most commonly reported as
difficult to afford (20%). Though it may seem like people who have problems paying for
supplements are more likely to have an unmet Rx need than those with problems affording
other medications, the trend is actually common across the board of medications and
supplements.
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Figure 9 highlights the unmet Rx need among people who already have problems paying
for medications. More than half of people with CF (55%) who had any difficulty affording
medications or supplements reported some unmet Rx need. Three-fifths (59%) of people
who had a problem paying for chronic inhaled antibiotics reported unmet Rx need.
Likewise, almost half (47%) of people who had difficulty affording vitamins and
supplements had unmet Rx need. Unmet Rx need varies from about 45% of people who had
problems paying for G-tube or NG-tube formula feeds, to 64% of those having trouble
paying for insulin.

Unsurprisingly, difficulty paying for medications and supplements is a key factor for
unmet Rx need. If people with CF are having problems affording their medications or
supplements this could be a warning sign that they are not taking medications.
In Table 4, we explore the odds of unmet Rx drug need if a person with CF has a problem
paying for any medications compared to a person with CF who has no problem affording
medications, adjusting for insurance and household income.
Table 4. Adjusted Odds Ratio of Unmet Rx Need by Problems Paying for Medications or
Supplements
Financial Burden
Adjusted Odds Ratio
No problem paying for medications
Any problem paying for medications

(Reference)
6.343***

Note: Odds ratios are adjusted to hold insurance and household income constant. ***
Denotes that statistically significant difference between the two groups at a p-value <.001.

The odds of unmet Rx need are six times higher among people who have a problem
paying for at least one medication or supplement than those that do not have any
problem paying for medications or supplements, holding insurance and household
income constant.
Household finances and medication affordability have a clear impact on unmet Rx need due
to cost. When a person with CF is struggling to meet their basic expenses or has difficulty
trying to pay for any medication, they are more likely to compensate by taking less
medicine or delaying filling a prescription.

CF Care Center Visits
The CF care center is a core component of care for people with CF. The CF Foundation has
established a standard of high-quality, specialized CF care that is centralized within
accredited care centers. The Foundation’s model for care is associated with more efficient
health care delivery and improvements in health outcomes (such as the median predicted
survival age) for patients.7,8 The model recommends people with CF make four routine
visits to their care center annually. People with CF are also likely to go to CF care centers
when sick unless they require some emergency care. As a result, we sought to examine
barriers to accessing CF care center care for both routine and sick visits, as well as the
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impact of these barriers on unmet Rx needs. As shown in Table 5, 10% of the sample
reported that they skipped a routine visit to their care center. Among those who skipped a
routine care center visit, 53% reported some problem paying for routine visits. In this same
group, 68% reported an unmet Rx need due to cost.
Table 5. Underutilization of CF Care Center Services and Unmet Rx Need

Percentage of
People with CF

Percentage Who Had a
Problem Paying for Care
Center Visit, Among Those
Who Delayed or Skipped
Care Center Visit

Percentage of Who Had
Any Unmet Rx Need,
Among Those Who
Delayed or Skipped Care
Center Visit

Skipped routine CF care
center visit(s)

10%

53%

68%

Delayed CF care center
visit when didn't feel well

10%

37%

68%

People with CF who delayed or skipped a care center visit due to cost are more likely to
also have a problem affording common medications and to delay or skip prescription
medications due to cost. This has potentially significant implications for assuring that
people with CF receive the appropriate specialized care to maintain health.
In Table 6, we explore the odds ratios of unmet Rx need if a person with CF delayed or
skipped care center visits compared to if a person with CF did not delay or skip care center
visits, adjusting for insurance and household income.
Table 6. Adjusted Odds Ratio of Unmet Rx Need by Delays in Care Center Visits
Care Center Access
Adjusted Odds Ratio
Routine Visit
Did not skip
Skipped
Sick Visit
Did not delay
Delayed

(Reference)
7.128***
(Reference)
6.664***

Note: Odds ratios are adjusted to hold insurance and household income
constant. *** Denotes that statistically significant difference between the
two groups at a p-value <.001.

The odds of unmet Rx need are seven times higher among people with CF that skipped
routine visits than among those who do not skip routine visits, holding insurance and
household income constant.
We also examined delayed care center visits when the person did not feel well. As shown in
Table 5, 10% of the sample reported delaying a sick visit to their care center. More than
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one-third (37%) of this group additionally had a problem paying for sick care center visits.
When we account for unmet Rx need, we find that 68% of people with CF who delayed sick
visits to their care center also delayed or skipped prescription medications due to cost. As
shown in Table 6, the odds of delayed prescription medications are 6.7 times higher

among people with CF that delay sick visits to their care center than among those who
do not delay sick visits, holding insurance and household income constant.
Unmet Rx need is undoubtedly tied to unmet medical need at CF care centers. People
with CF are more likely to delay or skip taking their medications if they are already
skipping or delaying their care center visits and having trouble affording care center
visits.

Conclusion
The costs of CF medications that fall onto the person with CF affect their ability to get care.
Family income and the cost of insurance play a critical role in preventing or exposing
people with CF to unmet Rx need. Our data indicate that aging out of childhood, lower
household income, gaps in coverage, and higher out-of-pocket costs to the patient greatly
increase the likelihood of unmet Rx need. Medicare beneficiaries seem to be vulnerable to
factors, such as higher out-of-pocket expenses, that prohibit them from maintaining
appropriate doses of medications. People with CF who already experience some financial
hardship, whether it’s affording their basic living expenses or the various medications and
ongoing care that they require, are also extremely vulnerable to unmet Rx need due to cost.
Interventions could be made to monitor use of recommended medications and offer
appropriate financial support when a person with CF experiences signs of financial
hardship or coverage inadequacies.
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